Bruce Sands, MD, MS, on When to Recommend a JAK Inhibitor for IBD

In this video, Bruce Sands, MD, MS, from the Icahn School of Medicine at Mount Sinai, discusses when a gastroenterologist should recommend a JAK inhibitor for the treatment of ulcerative colitis.

 

Bruce Sands, MD, MS, is the chief of the Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York. 

 

For more videos, visit the AIBD Newsroom.

 

Published in partnership with AIBD Annual Meeting

 

 

Submit Feedback

Name